Are you an opera singer who has worked in the American opera industry between 2000 and 2025? You may be eligible to participate in a research study about your professional experiences.

Would you like to be more active? Are you interested in knowing how it feels to walk inside compared to outside? Join our study to learn about walking on a treadmill and walking outside. By joining, you may help us learn more about body shape and size. No need to worry, we will guide you through everything! You can earn money for participating.

To evaluate the anti-tumor activity of carboplatin + MIRV in newly diagnosed subjects with advanced-stage (≥ 75%, ≥ 2+) serous EOC as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 imaging response.

Have you been recently diagnosed with T1D? You may be able to participate in a research study for an investigational cell therapy product to see if it is safe for patients with T1D and to see if it helps to slow down the progression of T1D.

Are you an Iranian woman between 35-50 living in the U.S.? Share your story about how social media affects your sense of identity, connection, and community. Your voice matters.

In this study, we want to look at how the drug tirzepatide works in patients with endometrial cancer compared to the standard of care treatment. We will be looking at its effect on the progression of the tumor.

We are doing this study to find out which type of shoulder surgery and rehab plan works best for certain kind of shoulder problem called anterior shoulder instability with mild bone loss. We want to see which surgery helps the shoulder heal strongest and gets people back to work or sports safely. We'll also look at what factors might raise the risk of problems after surgery, so doctors can better guide future patients.

Are you having rotator cuff surgery? You might be able to join a research study. This study is looking at BioEnthesis, a new surgical tool that might help your shoulder heal better. Joining this study could help improve care for other patients in the future.

Do you have a shoulder or arm injury diagnosed with an MRI? Or are you healthy and active? Join our study to help us learn how well ultrasound works compared to MRI for finding muscle and tendon problems. Your help can improve sports injury care in the future.

The standard treatment for newly-diagnosed multiple myeloma (NDMM) is autologous stem cell transplantation (ASCT). For this procedure, a patient's own healthy, blood-forming cells are collected. The patient then receives high-dose chemotherapy or radiation to kill the cancer cells. Then their healthy cells are returned to their body to recover. While ASCT is effective for many patients, it has significant side effects and may not be the best option for every patient with NDMM. In this research study, participants will receive one of two (2) study treatments: a new regimen of elranatamab plus daratumumab or a conventional regimen of ASCT plus lenalidomide and daratumumab. The delayed use of ASCT, as explored in this research study, is experimental and not standard-of-care.